


Healthcare News Roundup: Ophthalmology
HSMN NewsFeed - 13 Aug 2014
Inotek Pharmaceuticals Names David P. Southwell as President and Chief Executive Officer
Inotek Pharmaceuticals Names David P. Southwell as President and Chief Executive Officer
HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
